Coletiva de imprensa: anúncios do Governo 14/04/2021
Date:
14/02/2021
O Governador João Doria acompanhou nesta quarta-feira (14) a liberação de mais 1 milhão de doses da vacina do Instituto Butantan contra o coronavírus para uso em todo o país. Foi a 23° entrega até agora. Já foram disponibilizadas 40,7 milhões de doses ao PNI (Programa Nacional de Imunizações). Somente em abril foram 4,5 milhões.
“A vacina do Instituto Butantan, onde estamos, aqui em...
See more details
Betacoronavirus/immunology, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Immunization Programs/organization & administration, Pandemics/prevention & control, Local Health Systems/organization & administration, Hospital Bed Capacity/statistics & numerical data, Epidemiological Monitoring, Intensive Care Units/statistics & numerical data, Viral Vaccines/supply & distribution, Risk Groups, Aged, COVID-19, Plano São Paulo, Doria, João, Instituto Butantan, Coronavac, Sinovac Biotech, Vacina Já, Vacinômetro , AstraZeneca, Vacina de Oxford
A fase emergencial trouxe resultados?
Date:
12/04/2021
Saiba mais em www.saopaulo.sp.gov.br/coronavirus/planosp
See more details
Quarantine, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Epidemiological Monitoring, Hospital Bed Capacity, Intensive Care Units, COVID-19, Plano São Paulo
Coletiva de imprensa: anúncios do Governo - 09/04/2021
Date:
09/04/2021
O Vice-Governador Rodrigo Garcia anunciou, nesta sexta-feira (9), a antecipação da primeira etapa do plano de imunização dos trabalhadores da educação. O início da vacinação, inicialmente previsto para segunda-feira (12), poderá ocorrer já neste sábado (10) em todo estado. Nesta primeira fase, serão disponibilizadas 350 mil doses para os profissionais do setor.
“Nós havíamos anunc...
See more details
Betacoronavirus/immunology, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/statistics & numerical data, Immunization Programs/organization & administration, Viral Vaccines/supply & distribution, Local Health Systems/organization & administration, Risk Groups, Intensive Care Units/statistics & numerical data, Hospital Bed Capacity/statistics & numerical data, Epidemiological Monitoring, Social Isolation, Quarantine/organization & administration, Faculty, Aged, Health Personnel, Schools/organization & administration, Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, COVID-19, Plano São Paulo, Garcia, Rodrigo , Instituto Butantan, Coronavac, Sinovac Biotech, Vacinômetro
Coletiva de imprensa: anúncios do Governo - 07/04/2021
Date:
07/04/2021
O Governador João Doria anunciou nesta quarta-feira (7) a ampliação da campanha de vacinação contra COVID-19 para idosos com idade entre 65 e 67 anos ainda em abril. O novo grupo totaliza 1,11 milhão de pessoas. O avanço da campanha depende da chegada das vacinas da Fiocruz ainda nesta semana para êxito no cronograma definido pelo PEI (Plano Estadual de Imunização).
O objetivo é iniciar...
See more details
Betacoronavirus/immunology, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Immunization Programs/organization & administration, Viral Vaccines/supply & distribution, Pandemics/prevention & control, Epidemiological Monitoring, Risk Groups, Hospital Bed Capacity/statistics & numerical data, Intensive Care Units/statistics & numerical data, Social Programs/policies, Local Health Systems/organization & administration, Oxygen/supply & distribution, 34658, COVID-19, Plano São Paulo, Doria, João, Coronavac, Instituto Butantan, Sinovac Biotech, Bolsa do Povo
Media briefing on COVID-19 - 06/04/2021
Date:
06/04/2021
00:00:17
CL Hello, good day and welcome, wherever you are listening today. It is Tuesday 6th April 2021. My name is Christian Lindmeier and I'm welcoming you to today's global COVID-19 press conference ahead of World Health Day, which we celebrate on 7th April.
Therefore we have a list of very special guests online with us today. We'll start with Her Excellency Prime Minister Mia Mottley...
See more details
Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Pandemics/prevention & control, Americas/epidemiology, Health Equity, Oxygen/supply & distribution, Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Viral Vaccines/supply & distribution, Immunization Programs/organization & administration, Health Consortia, Risk Groups, Access to Essential Medicines and Health Technologies, Healthcare Financing, Health Systems/economics, Vulnerable Populations, Universal Health Insurance, Health Information Systems, Epidemiological Monitoring, COVID-19, Ghebreyesus, Tedros Adhanom , Covax
WHO's strategic preparedness and response plan to COVID-19
Date:
15/01/2021
Visit WHO’s COVID-19 preparedness and response plan to combat COVID-19
https://www.who.int/emergencies/disea...
To learn more about our technical guidance repertoire and situation reports for more information on our support to countries, as well as the WHO Academy for support to health workers worldwide and the OpenWHO training for current outbreaks:
https://www.who.int/emergencies/disea.....
See more details
Pneumonia, Viral/prevention & control, Coronavirus Infections/prevention & control, Access to Essential Medicines and Health Technologies, Pandemics/prevention & control, Epidemiological Monitoring, World Health Organization, COVID-19
Dr Tedros opening remarks: WHO-UN DESA technical advisory group on COVID-19 mortality assessment
Date:
01/03/2021
The WHO - UN DESA Technical Advisory Group on COVID-19 Mortality Assessment acts as an advisory body to both WHO and UNDESA on COVID-19 mortality assessment. The TAG will advise and support efforts to assist WHO and UN Member States to obtain accurate estimates of the number of deaths attributable to the direct and indirect impacts of the pandemic. The TAG comprises a global network of experts fro...
See more details
Coronavirus Infections/mortality, Pneumonia, Viral/mortality, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Epidemiological Monitoring, Health Information Systems/organization & administration, World Health Organization, COVID-19
Sharing COVID-19 experiences: the El Salvador response
Date:
27/02/2021
El Salvador responded rapidly and effectively to the emergence of the SARS-CoV-2 virus in the country. In line with WHO advice, El Salvador stepped up preparedness of its health system in mid-January and announced a national emergency on 30 January, the same day that WHO declared COVID-19 a public health emergency of international concern. El Salvador’s strong response has been built on equippin...
See more details
Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Betacoronavirus/immunology, Pandemics/prevention & control, Viral Vaccines/supply & distribution, Epidemiological Monitoring, El Salvador/epidemiology, Health Systems/organization & administration, Quarantine/organization & administration, Social Isolation, Access to Essential Medicines and Health Technologies, Polymerase Chain Reaction/methods, Health Personnel/education, COVID-19
Live Q&A on COVID-19 and vulnerable populations with Dr Mike Ryan, Filippo Grandi, Teresa Zakaria
Date:
24/02/2021
See more details
Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Pneumonia, Viral/prevention & control, Coronavirus Infections/prevention & control, Betacoronavirus/immunology, Pandemics/prevention & control, Viral Vaccines/supply & distribution, Epidemiological Monitoring, Health Communication, Social Isolation, Quarantine, Vulnerable Populations, Refugee Camps, Health Services Accessibility, Immunization Programs/organization & administration, COVID-19, Covax
WHO SAGE presenting its interim recommendations on the use of AstraZeneca Vaccine against COVID-19
Date:
10/02/2021
See more details
Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Pneumonia, Viral/prevention & control, Viral Vaccines/immunology, Betacoronavirus/immunology, Epidemiological Monitoring, Health Communication, Viral Vaccines/supply & distribution, Vaccine Potency, Betacoronavirus/genetics, Mutation/genetics, DNA, Viral/genetics, Coronavirus Infections/genetics, Pneumonia, Viral/genetics, Risk Groups, COVID-19, AstraZeneca, Oxford